{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:55:19Z","timestamp":1761519319127},"reference-count":27,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0613","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T22:06:17Z","timestamp":1608761177000},"page":"477-484","source":"Crossref","is-referenced-by-count":18,"title":["Successful management of a patient with active Cushing\u2019s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia"],"prefix":"10.1507","volume":"68","author":[{"given":"Akiko","family":"Yuno","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kin-ikyo Chuo Hospital, Sapporo 007-8505, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kenmotsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kin-ikyo Chuo Hospital, Sapporo 007-8505, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nomoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Kameda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Yong","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Nakakubo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kamada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sugino","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Sawamura","sequence":"additional","affiliation":[{"name":"Sawamura Neurosurgery Clinic, Sapporo 060-0807, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Advanced Medical Care Center, Kusatsu General Hospital, Kusatsu 525-8585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, et al. (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic\u2014an international perspective. Pituitary 23: 327\u2013337.","DOI":"10.1007\/s11102-020-01059-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, et al. (2020) COVID-19 and Cushing\u2019s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol 8: 654\u2013656.","DOI":"10.1016\/S2213-8587(20)30215-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Newell-Price J, Nieman LK, Reincke M, Tabarin A (2020) Endocrinology in the time of COVID-19: management of Cushing\u2019s syndrome. Eur J Endocrinol 183: G1\u2013G7.","DOI":"10.1530\/EJE-20-0352"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, et al. (2020) The impact of SARS-CoV-2 virus infection on the endocrine system. J Endocr Soc 4: bvaa082.","DOI":"10.1210\/jendso\/bvaa082"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, et al. (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126: 123\u2013135.","DOI":"10.1007\/s00401-013-1084-y"},{"key":"6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"6 Wang D, Hu B, Hu C, Zhu F, Liu X, et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323: 1061\u20131069.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wu C, Chen X, Cai Y, Xia Ja, Zhou X, et al. (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180: 934\u2013943.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, et al. (2020) How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol 183: 389\u2013397.","DOI":"10.1530\/EJE-20-0541"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, et al. (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4: 611\u2013629.","DOI":"10.1016\/S2213-8587(16)00086-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Aranda G, Lopez C, Fernandez-Ruiz R, Esteban Y, Garcia-Eguren G, et al. (2017) Circulatory immune cells in Cushing syndrome: bystanders or active contributors to atherometabolic injury? A study of adhesion and activation of cell surface markers. Int J Endocrinol 2017: 2912763.","DOI":"10.1155\/2017\/2912763"},{"key":"11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"11 Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, et al. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271\u2013280.e8.","journal-title":"Cell","ISSN":"http:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"12","unstructured":"12 Levi M, Thachil J, Iba T, Levy JH (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 7: e438\u2013e440."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, et al. (2015) Treatment of Cushing\u2019s syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100: 2807\u20132831.","DOI":"10.1210\/jc.2015-1818"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 The RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N Engl J Med 384: 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324: 1330\u20131341.","DOI":"10.1001\/jama.2020.17023"},{"key":"16","unstructured":"16 (2020) Corticosteroids for COVID-19: World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1 accessed on September 2,2020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, et al. (2015) Effectiveness of metyrapone in treating Cushing\u2019s syndrome: a retrospective multicenter study in 195 patients. J Clin Endocrinol Metab 100: 4146\u20134154.","DOI":"10.1210\/jc.2015-2616"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, et al. (2020) Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase. Lancet Diabetes Endocrinol 8: 748\u2013761.","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, et al. (2011) Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11-hydroxylase inhibitor metyrapone. Ann Clin Biochem 48: 441\u2013446.","DOI":"10.1258\/acb.2011.011014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Epperla N, McKiernan F (2015) Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone. SpringerPlus 4: 455.","DOI":"10.1186\/s40064-015-1218-x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Chen G, Wu D, Guo W, Cao Y, Huang D, et al. (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130: 2620\u20132629.","DOI":"10.1172\/JCI137244"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Annane D, Pastores SM, Arlt W, Balk RA, Beishuizen A, et al. (2017) Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European society of intensive care medicine (ESICM). Intensive Care Med 43: 1781\u20131792.","DOI":"10.1007\/s00134-017-4914-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Leow MK-S, Kwek DS-K, Ng AW-K, Ong K-C, Kaw GJ-L, et al. (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63: 197\u2013202.","DOI":"10.1111\/j.1365-2265.2005.02325.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Valassi E, Aulinas A, Glad CA, Johannsson G, Ragnarsson O, et al. (2017) A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 87: 433\u2013439.","DOI":"10.1111\/cen.13414"},{"key":"25","unstructured":"25 Zhu W, Huang X, Zhao H, Jiang X (2020) A COVID-19 patient who underwent endonasal endoscopic pituitary adenoma resection: a case report. Neurosurgery 87: E140\u2013E146."},{"key":"26","unstructured":"26 Cai Q, Yang M, Liu D, Chen J, Shu D, et al. (2020) Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering (Beijing) 6: 1192\u20131198."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Doi K, Ikeda M, Hayase N, Moriya K, Morimura N (2020) Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series. Crit Care 24: 392.","DOI":"10.1186\/s13054-020-03078-z"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/4\/68_EJ20-0613\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:29:35Z","timestamp":1619839775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/4\/68_EJ20-0613\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0613","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}